Treating hypertension in the very elderly-benefits, risks, and future directions, a focus on the hypertension in the very elderly trial.
Peters, Ruth;
Beckett, Nigel;
McCormack, Terry;
Fagard, Robert;
Fletcher, Astrid;
Bulpitt, Christopher;
(2013)
Treating hypertension in the very elderly-benefits, risks, and future directions, a focus on the hypertension in the very elderly trial.
European heart journal, 35 (26).
pp. 1712-1718.
ISSN 0195-668X
DOI: https://doi.org/10.1093/eurheartj/eht464
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Although the number of individuals reaching 80 who are considered to be healthy is increasing, the very elderly are likely to have long-term conditions, to report symptoms and/or be taking at least one regular medication. The impact of antihypertensive treatment has to be taken into account in this context. The treatment regimen in Hypertension in the Very Elderly Trial with a goal blood pressure of <150/80 mmHg has been shown to provide benefits in terms of a reduction in risk of total mortality, stroke, and cardiovascular events with potential benefits and no evidence of increased risk for fracture, dementia, depression, and quality-of-life outcomes. Questions remain as to the level of benefit that would be accrued in the frailer elderly and those at extreme age, for example, over 90.
